Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 9 , Pages 1642-1647 , September 2008

Branched-Chain Amino Acids May Improve Recovery From a Vegetative or Minimally Conscious State in Patients With Traumatic Brain Injury: A Pilot Study

  • Roberto Aquilani, MD

      Affiliations

    • Servizio di Fisiopatologia Metabolico-Nutrizionale e Nutrizione Clinica, Fondazione S. Maugeri, Istituto Scientifico di Montescano, Montescano, Pavia, Italy
  • ,
  • Mirella Boselli, MD

      Affiliations

    • Divisione II di Neuroriabilitazione, Fondazione S. Maugeri, Istituto Scientifico di Montescano, Montescano, Pavia, Italy
  • ,
  • Federica Boschi, PhD

      Affiliations

    • Dipartimento di Scienze Fisiologiche-Farmacologiche Cellulari-Molecolari, Sezione di Farmacologia e Biotecnologie Farmacologiche, Pavia, Italy
  • ,
  • Simona Viglio, PhD

      Affiliations

    • Dipartimento di Biochimica “A. Castellani” Università degli Studi di Pavia, Pavia, Italy
  • ,
  • Paolo Iadarola, PhD

      Affiliations

    • Dipartimento di Biochimica “A. Castellani” Università degli Studi di Pavia, Pavia, Italy
  • ,
  • Maurizia Dossena, PhD

      Affiliations

    • Dipartimento di Scienze Fisiologiche-Farmacologiche Cellulari-Molecolari, Sezione di Farmacologia e Biotecnologie Farmacologiche, Pavia, Italy
  • ,
  • Ornella Pastoris, PhD

      Affiliations

    • Dipartimento di Scienze Fisiologiche-Farmacologiche Cellulari-Molecolari, Sezione di Farmacologia e Biotecnologie Farmacologiche, Pavia, Italy
    • Corresponding Author InformationReprint requests to Ornella Pastoris, PhD, Dipartimento di Scienze Fisiologiche-Farmacologiche Cellulari-Molecolari, Sezione di Farmacologia e Biotecnologie Farmacologiche, Facoltà di Scienze MM. FF. NN., Università degli Studi di Pavia-Piazza Botta, Pavia, 11-27100, Italy
  • ,
  • Manuela Verri, PhD

      Affiliations

    • Dipartimento di Scienze Fisiologiche-Farmacologiche Cellulari-Molecolari, Sezione di Farmacologia e Biotecnologie Farmacologiche, Pavia, Italy

References 

  1. American Congress of Rehabilitation Medicine. Recommendations for use of uniform nomenclature pertinent to patients with severe alterations in consciousness. Arch Phys Med Rehabil. 1995;76:205–209
  2. Zampolini M on the behalf of the Giscar Group. La riabilitazione delle persone con grave cerebrolesione traumatica in Italia: dati finali dello Studio Giscar. Eur Med Phys. 2005;41(Suppl 1-4):81–85
  3. Verweij BH, Muizelaar JP, Vinas FC, Peterson PL, Xiong Y, Lee CP. Impaired cerebral mitochondrial function after traumatic brain injury in humans. J Neurosurg. 2000;93:815–820
  4. Bergsneider M, Hovda DA, Shalmon E, et al. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg. 1997;86:241–251
  5. Yoshino A, Hovda DA, Katayama Y, Kawamata T, Becker DP. Hippocampal CA3 lesion prevents postconcussive metabolic dysfunction in CA1. J Cereb Blood Flow Metab. 1992;12:996–1006
  6. Wu HM, Huang SC, Hattori N, et al. Selective metabolic reduction in gray matter acutely following human traumatic brain injury. J Neurotrauma. 2004;21:149–161
  7. Wu HM, Huang SC, Hattori N, et al. Subcortical white matter metabolic changes remote from focal hemorrhagic lesions suggest diffuse injury after human traumatic brain injury. Neurosurgery. 2004;55:1306–1317
  8. Ahmed SM, Rzigalinski A, Willoughby KA, Sitterding HA, Ellis EF. Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J Neurochem. 2000;74:1951–1960
  9. Erecinska M, Silver IA. ATP and brain function. J Cereb Blood Flow Metab. 1989;9:2–19
  10. Adams JH, Graham DI, Jennett B. The neuropathology of the vegetative state after an acute brain insult. Brain. 2000;123:1327–1338
  11. Lehninger AL. Principi di biochimica. Bologna: Ed. Zanichelli; 1983.
  12. Layman DK. Role of leucine in protein metabolism during exercise and recovery. Can J Appl Physiol. 2002;27:646–662
  13. Volpi E, Ferrando AA, Yeckel CW, Tipton KD, Wolfe RR. Exogenous amino acids stimulate net muscle protein synthesis in the elderly. J Clin Invest. 1998;101:2000–2007
  14. Biolo G, Tipton KD, Klein S, Wolfe RR. An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am J Physiol. 1997;273:E122–E129
  15. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In:  Siegel GJ,  Agranoff BW,  Albers RW,  Fisher SK,  Uhler MD editor. Basic neurochemistry. Philadelphia: Lippincott-Raven; 1998;p. 637–669
  16. Xu G, Kwon G, Marshall CA, Lin TA, Lawrence JC, McDaniel ML. Branched chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells: a possible role in protein translation and mitogenic signalling. J Biol Chem. 1998;273:78–84
  17. Davis SN, Colburn C, Dobbins R, et al. Evidence that the brain of the conscious dog is insulin sensitive. J Clin Invest. 1995;95:593–602
  18. Park CR. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev. 2001;25:311–323
  19. Aquilani R, Iadarola P, Contardi A, et al. Branched-chain amino acids enhance the cognitive recovery of patients with severe traumatic brain injury. Arch Phys Med Rehabil. 2005;86:1729–1735
  20. Rappaport M, Hall K, Hopkins K, Belleza T, Berrol S, Reynolds G. Evoked brain potentials and disability in brain-damaged patients. Arch Phys Med Rehabil. 1977;58:333–338
  21. Gouvier WD, Blanton PD, LaPorte KK, Nepomuceno C. Reliability and validity of the disability rating scale and the levels of cognitive functioning scale in monitoring recovery from severe head injury. Arch Phys Med Rehabil. 1987;68:94–97
  22. Whyte J, Katz D, Long D, et al. Predictors of outcome in prolonged post traumatic disorders of consciousness and assessment of medication effects: a multicenter study. Arch Phys Med Rehabil. 2005;86:453–462
  23. Giacino JT, Kezmarsky MA, DeLuca J, Cicerone KD. Monitoring rate of recovery to predict outcome in minimally responsive patients. Arch Phys Med Rehabil. 1991;72:897–901
  24. Fernstrom JD, Faller DV. Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem. 1978;30:1531–1538
  25. Chaplin ER, Goldberg AL, Diamond I. Leucine oxidation in brain slices and nerve endings. J Neurochem. 1976;26:701–707
  26. Gaitonde MK, Evison E, Evans GM. The rate of utilization of glucose via hexose monophosphate shunt in brain. J Neurochem. 1983;41:1253–1260
  27. Meythaler JM, Peduzzi JD, Eleftheriou E, Novack TA. Current concepts: diffuse axonal injury-associated traumatic brain injury. Arch Phys Med Rehabil. 2001;82:1461–1471
  28. Tavalin SJ, Ellis EF, Satin LS. Inhibition of the electrogenic Na pump underlies delayed depolarization of cortical neurons after mechanical injury or glutamate. J Neurophysiol. 1997;77:632–638
  29. Mattson MP. Neuroprotective signal transduction: relevance to stroke. Neurosci Biobehav Rev. 1997;1:193–206
  30. Paschen W, Frandsen A. Endoplasmic reticulum dysfunction: a common denominator for cell injury in acute and degenerative diseases of the brain?. J Neurochem. 2001;79:719–725
  31. Muir JK, Tynan M, Caldwell R, Ellis EF. Superoxide dismutase improves cortical blood flow in rats. J Neurotrauma. 1995;12:179–188
  32. Hall ED, Smith SL, Oostveen JA. Inhibition of lipid peroxidation attenuates axotomy-induced apoptotic degeneration of facial motor neurons in neonatal rats. J Neurosci Res. 1996;44:293–299
  33. Hoffman SW, Moore S, Ellis EF. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke. 1997;28:844–849
  34. Shohami ES, Beit-Yannai E, Horowitz M, Kohen R. Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood Flow Metab. 1997;17:1007–1019
  35. Lamb RG, Harper CC, McKinney JS, Rzigacinski BA, Ellis EF. Alterations in phosphatidylcholine metabolism of stretch injured cultured rat astrocytes. J Neurochem. 1997;68:1904–1910
  36. Stenoiden DL, Brady ST. Axonal transport. In:  Siegel GJ,  Agranoff BW,  Albers RW,  Fisher SK,  Uhler MD editor. Basic neurochemistry. Philadelphia: Lippincott Raven; 1998;p. 565–587
  37. Goldman-Rakic PS. Cellular basis of working memory. Neuron. 1995;14:477–485
  38. Costantinidis C, Williams GV, Goldman-Rakic PS. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat Neurosci. 2002;5:175–180
  39. Chen SF, Richards HK, Smielewski P, et al. Relationship between flow-metabolism uncoupling and evolving axonal injury after experimental traumatic brain injury. J Cereb Blood Flow Metab. 2004;24:1025–1036
  40. Cotman CW, Nieto-Sampedro M, Harris EW. Synapse replacement in the nervous system of adult vertebrates. Physiol Rev. 1981;61:684–784
  41. Marks JL, King MG, Baskin DG. Localization of insulin and type I IGF receptors in rat brain by in vitro autoradiography and in situ hybridization. Adv Exp Med Biol. 1991;293:459–470
  42. Zhao WQ, Alkon DL. Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol. 2001;177:125–134
  43. Stockhorst U, de Fries D, Steingrueber HJ, Scherbaum WA. Insulin and the CNS: effects on food intake, memory and endocrine parameters and the role of intranasal insulin administration in humans. Physiol Behav. 2004;83:47–54
  44. Sweeney G, Klip A. Regulation of the Na+/K+-ATPase by insulin: why and how?. Mol Cell Biochem. 1998;182:121–133
  45. Spanswick D, Smith MA, Mirshamsi S, Routh VH, Ashford ML. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci. 2000;3:57–58
  46. Jonas EA, Knox RJ, Smith TC, Wayne NL, Connor JA, Kaczmarek LK. Regulation by insulin of a unique neuronal Ca++ pool and of neuropeptide secretion. Nature. 1997;385:343–346
  47. Reizada MK, Shemer JM, Judkins JH, Clarke DW, Master BA, LeRoith D. Insulin receptors in the brain: structural and physiological characterization. Neurochem Res. 1988;13:297–303
  48. Masters BA, Shemer JM, Judkins JH, Clarke DW, LeRoith D, Raizada MK. Insulin receptors in the brain: structural and physiological characterization. Brain Res. 1987;417:247–256
  49. Christie JM, Wenthold RJ, Monaghan DT. Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus. J Neurochem. 1999;72:1523–1528
  50. Wan Q, Xiong ZG, Man HY, et al. Recruitment of functional GABAA receptors to postsynaptic domains by insulin. Nature. 1997;388:686–690
  51. Ma XH, Zhong P, Gu Z, Feng J, Yan Z. Muscarinic potentiation of GABAA receptor currents is gated by insulin signalling in the prefrontal cortex. J Neuroscience. 2003;15:1159–1168
  52. Fliglewicz DP, Patterson TA, Zavosh A, Brot MD, Roitman M, Szot P. Neurotransmitter transporters: target for endocrine regulation. Horm Metab Res. 1999;31:335–339
  53. Park CR, Seeley RJ, Craft S, Woods SC. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav. 2000;68:509–514
  54. Kern W, Born J, Fehm HL. Role of insulin in Alzheimer's disease: approaches emerging from basic annual research and neurocognitive studies in humans. Drug Dev Res. 2002;56:511–525
  55. Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL. Improving influence of insulin on cognitive functions in humans. Neuroendocrinology. 2001;74:270–280
  56. Eichenbaum H, Otto T, Cohen NJ. The hippocampus: what does it do?. Behav Neural Biol. 1992;57:2–36
  57. Henneberg N, Hoyer S. Short-term or long-term intracerebroventricular (i.c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat. Neurosci Lett. 1994;175:153–156
  58. Ragozzino ME, Unick KE, Gold PE. Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc Natl Acad Sci U S A. 1996;93:4693–4698
  59. Ragozzino ME, Pall SN, Unick KE, Stefani MR, Gold PE. Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections. J Neurosci. 1998;18:1595–1601
  60. Cadoux-Hudson TA, Wade D, Taylor DJ, et al. Persistent metabolic sequelae of severe head injury in humans in vivo. Acta Neurochir (Wien). 1990;104:1–7
  61. Medical aspects of the persistent vegetative state (2). The Multi-Society Task Force on PVS [published erratum in: N Engl J Med 1995;333:130]. N Engl J Med. 1994;330:1572–1579

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated.

PII: S0003-9993(08)00406-1

doi: 10.1016/j.apmr.2008.02.023

Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 9 , Pages 1642-1647 , September 2008